Should we use extracorporeal photopheresis more often? Evidence from graft-versus-host disease patients monitored with Treg as a biomarker.

Sérgio Machado LopesSusana RonconAna Catarina PinhoFilipa BordaloLuís AntunesFernando CampilhoAntónio CamposAltamiro Costa-Pereira

Published in: Future science OA (2020)

In these patients, the improvement of cGvHD, with low AEs, confirms a place for ECP as treatment. Improvements were accompanied by an increase in circulating Tregs, suggesting their role as a biomarker.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes
patient reported